NTRK GENE FUSION CANCER

This adverse event was reported 4 times

NTRK GENE FUSION CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAROTRECTINIB 2 0.0022
1 REGORAFENIB 1 0.0001
2 IFOSFAMIDE FOR INJECTION 1 0.0000
3 TAPENTADOL HYDROCHLORIDE 1 0.0000
4 TRAMADOL HYDROCHLORIDE 1 0.0000
5 FENTANYL 2 0.0000
6 DOCUSATE SODIUM 1 0.0000
7 PREGABALIN 1 0.0000
8 ACETAMINOPHEN 1 0.0000
See all drugs enriched for association with NTRK GENE FUSION CANCER

These drug classes are most commonly taken by patients reporting NTRK GENE FUSION CANCER:

# Drug class Count
0 Kinase Inhibitor [EPC] 2
1 Opioid Agonist [EPC] 2
2 Alkylating Drug [EPC] 1
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1
See all common drug classes associated with NTRK GENE FUSION CANCER

NTRK GENE FUSION CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Agonist [EPC] 2 0.0000
1 Alkylating Drug [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 2 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with NTRK GENE FUSION CANCER